Biotech Stock News (IMGN) (RGLS) (GILD) (ACHN) (OPK) (BRLI)

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy … Read more

ImmunoGen (IMGN) Stock | Looking For Another Breakout

ImmunoGen, Inc. (NASDAQ: IMGN) ImmunoGen has been a relatively interesting stock to watch this week. After climbing in a big way Monday following a presentation, the company’s stock fell yesterday and seems to be trading flat today. However, I’m not too concerned. As a matter of fact, I’m looking for another breakout from IMGN. Today, … Read more

ImmunoGen Stock Is Declining | Why I’m Not Concerned

ImmunoGen, Inc. (NASDAQ: IMGN) ImmunoGen stock had an absolutely amazing day yesterday. After releasing Phase 1 trial results of an experimental ovarian cancer treatment, the company’s stock skyrocketed; gaining roughly 72% in a single day yesterday and reaching a 14-month high! However, the story seems to be a bit different today. Unfortunately the stock is … Read more

BioTech Stocks | Today’s Biggest Gainers

Biggest Gaining BioTech Stock Today – ImmunoGen, Inc. (NASDAQ: IMGN) After reporting that Takeda Pharmaceutical (NASDAQOTH: TKPHF) has licensed it’s antibody-drug, ImmunoGen stocks skyrocketed. Today, the stock gained $1.25 per share or 16.80%; closing the day off at $8.69 per share. Second Biggest Gaining BioTech Stock Today – Herbalife Ltd. (NYSE: HLF) Herbalife stocks have … Read more